Navigation Links
Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15

LA JOLLA, Calif. (PRWEB) July 11, 2013

WHAT: CHI-California Healthcare Institute is hosting Pipeline for Life: Revitalizing Our Biomedical Research Ecosystem for a Healthier Tomorrow in La Jolla, California. Sequestration is putting enormous pressure on government funding for research programs that form the scientific base for innovative medical advances for patients.

WHO: Top academic leaders and industry executives from: Allergan, Bristol-Myers Squibb, Cedars-Sinai, Bay City Capital, Genzyme, The Scripps Research Institute, J. Gladstone Institutes, Gilead Sciences, Bay City Capital, City of Hope, Thermo Fisher Scientific, Health and policy experts from CHI, University of California, Irvine, University of California, San Diego and more.

WHY: At Pipeline for Life, California Healthcare Institute (CHI) will convene an extraordinary group of biomedical industry leaders and influential policymakers for focused discussions on success in basic research, public policy, modernizing innovation and strategy while reshaping the market for medical innovation and research inspiration for success in new therapies and medical technologies. This event brings together representatives from CHI’s member organizations with policymakers to discuss critical issues and opportunities facing the biomedical community. The goal of the Pipeline for Life is to produce a clearer understanding of the biomedical community’s work and needs, and how the industry can sustain California’s leadership in biomedical research and innovation.

WHO SHOULD ATTEND: Leaders from California’s biomedical industry, academic research community, entrepreneurs, healthcare providers, investors, members of the media, policy experts and patient advocates.

WHEN: Monday, July 15, 2013
Registration: 11:30 a.m. – noon
Welcoming Lunch: noon - 1:10 p.m.
Panel discussions and keynotes: 1:15 – 5:00 p.m.
Reception: 5–6 p.m.

WHERE: The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California

For more information, visit

Media Inquiries & Event Registration:
Erica Hiar

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Crowdfunding Expert Kendall Almerico Discusses Crowdfunding for Science
2. SPIE Leaders Commend OMB Support for Travel to Scientific Conferences, Say Funding is Also Needed
3. Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding
4. NSBRI Industry Forum Launches SMARTCAP-Accel, a Grant Funding Opportunity to Catalyze Development of Products for Spaceflight
5. Patheon to Host Complimentary Seminar on “Formulation, Funding and First-in-Man: A Stepwise Guide to Clinical Success”
6. NIH Saves Lives: Fred Hutchinson Cancer Research Center Calls On Congress To Restore Full NIH Funding
7. Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations
8. SPIE Encouraged By Increased Science Funding in Obama Budget, Urges Applied Research Emphasis
9. Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.
10. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
11. VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
Post Your Comments:
(Date:11/24/2015)... 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) ... president and chief executive officer, will present at the 27 ... New York City . The presentation will ... 2015 at 9:30 a.m. EST. and ... at least 15 minutes prior to the presentation to allow ...
(Date:11/24/2015)... According to two new studies, fewer men are having PSA ... doctors, scientists, and public health experts have been pushing for ... being done, will there be more men dying of ... "Despite the efforts made in regards to early detection for ... of death in men, killing approximately 27,500 men this year. ...
(Date:11/23/2015)... 2015 China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... preliminary unaudited financial results for the second quarter and ... 2015. --> --> ... for the second quarter of fiscal 2016 increased by ...
(Date:11/23/2015)... , November 23, 2015 ... to develop daclatasvir for 112 ... countries   --> --> ... for a hepatitis C medicine, signing an agreement with Bristol-Myers ... to help cure multiple genotypes of the HCV virus.  The ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):